Segnan, Nereo.
Nereo Segnan
Segnan, N. (Nereo)
Segnan, N.
VIAF ID: 146191543 (Personal)
Permalink: http://viaf.org/viaf/146191543
Preferred Forms
- 100 0 _ ‡a Nereo Segnan
-
-
-
-
- 100 1 _ ‡a Segnan, N. ‡q (Nereo)
-
- 100 1 _ ‡a Segnan, Nereo
- 100 1 _ ‡a Segnan, Nereo
-
-
- 100 1 _ ‡a Segnan, Nereo
- 100 1 _ ‡a Segnan, Nereo
-
-
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Accessibility as a major determinant of radiotherapy underutilization: a population based study | |
Appropriateness of early breast cancer management in relation to patient and hospital characteristics: a population based study in Northern Italy | |
Cervical screening according to age and HPV status | |
Comparing participants and nonparticipants in a smoking cessation trial: selection factors associated with general practitioner recruitment activity | |
Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in Italy | |
Computer-aided detection for computed tomographic colonography screening: a prospective comparison of a double-reading paradigm with first-reader computer-aided detection against second-reader computer-aided detection | |
The differential diagnosis of primary lung cancer: inter-observer agreement and contribution of specific diagnostic procedures | |
Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results? | |
Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications | |
Early diagnosis, not differential treatment, explains better survival in service screening. | |
Effect of circulation and discussion of cervical smears on agreement between laboratories | |
Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials | |
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction. | |
Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | |
Epidemiologic evidence of slow growing, nonprogressive or regressive breast cancer: A systematic review | |
Epidemiology of respiratory cancers related to nickel mining and refining in New Caledonia (1978-1984) | |
Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy | |
The EUROMED CANCER network: state-of-art of cancer screening programmes in non-EU Mediterranean countries. | |
European Code against Cancer, 4th Edition: Cancer screening | |
European guidelines for quality assurance in colorectal cancer screening and diagnosis | |
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis | |
Evidence of a multiplicative effect between cigarette smoking and occupational exposures in the aetiology of bladder cancer. | |
Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme | |
Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers | |
A high positive predictive value algorithm using hospital administrative data identified incident cancer cases | |
High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test | |
HPV-based screening for prevention of invasive cervical cancer - Authors' reply | |
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. | |
Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial | |
Human papillomavirus typing with GP5+/6+ polymerase chain reaction reverse line blotting and with commercial type-specific PCR kits | |
The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. | |
The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective | |
Impact of the AutoPap (currently focalpoint) primary screening system location guide use on interpretation time and diagnosis | |
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial | |
Inter-observer and intra-observer variability of mammogram interpretation: a field study. | |
Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy | |
International variation in management of screen-detected ductal carcinoma in situ of the breast | |
Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter | |
Is the breast cancer mortality decrease in Sweden due to screening or treatment? Not the right question | |
Lifetime growth and risk of testicular cancer | |
Mammographic screening programmes in Europe: organization, coverage and participation | |
Modelling patterns of clearance of HPV-16 infection and vaccination efficacy | |
Monitoring surgical treatment of screen-detected breast lesions in Italy | |
Narrow band imaging vs. high definition colonoscopy for detection of colorectal adenomas in patients with positive faecal occult blood test: a randomised trial | |
Optimising colorectal cancer screening acceptance: a review | |
Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature | |
Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial | |
Predicting proximal advanced neoplasms at screening sigmoidoscopy | |
Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population | |
Predictors of smoking cessation following physicians' counseling | |
Prevalence of human papillomavirus infection in women in Turin, Italy | |
Prijevod europskih smjernica za osiguranje kvalitete probira i dijagnostike raka debelog crijeva | |
Randomized Trial of Different Screening Strategies for Colorectal Cancer: Patient Response and Detection Rates | |
Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status | |
Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials | |
Retrospective evaluation of occupational exposures in cancer epidemiology: a European concerted action of research | |
Sun exposure prior to diagnosis is associated with improved survival in melanoma patients: Results from a long-term follow-up study of Italian patients | |
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. | |
Virtual microscopy for histology quality assurance of screen-detected polyps. | |
What information do breast cancer screening programmes provide to Italian women? | |
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination | |
Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes | |
Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). |